Association between TSH suppression therapy and type 2 deiodinase gene polymorphism in differentiate...
Association between TSH suppression therapy and type 2 deiodinase gene polymorphism in differentiated thyroid carcinoma
About this item
Full title
Author / Creator
Publisher
Wydawnictwo Via Medica
Journal title
Language
English
Formats
Publication information
Publisher
Wydawnictwo Via Medica
Subjects
More information
Scope and Contents
Contents
INTRODUCTION: Oral levothyroxine (L-T4) suppression of thyroid-stimulating hormone (TSH) levels is the most commonly used clinical approach to manage and treat patients after thyroid cancer surgery. This study aimed to investigate the association between TSH suppression therapy and type 2 deiodinase gene (DIO2) polymorphism in differentiated thyroi...
Alternative Titles
Full title
Association between TSH suppression therapy and type 2 deiodinase gene polymorphism in differentiated thyroid carcinoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2863245471
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2863245471
Other Identifiers
ISSN
0423-104X
E-ISSN
2299-8306
DOI
10.5603/EP.a2023.0043
